Education
About Us
Working with TipRanks
Follow Us
Hims & Hers Health (HIMS)
NYSE:HIMS
HIMS Stock Chart & Stats
$33.87
-$0.61(-2.20%)
At close: 4:00 PM EST
$33.87
-$0.61(-2.20%)
Day’s Range― - ―
52-Week Range$23.97 - $72.98
Previous CloseN/A
Volume4.28M
Average Volume (3M)11.72M
Market Cap
$7.21B
Enterprise Value$14.59B
Total Cash (Recent Filing)$629.74M
Total Debt (Recent Filing)$1.12B
Price to Earnings (P/E)59.8
Beta2.62
Next Earnings
Mar 02, 2026EPS Estimate
0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding219,270,890
10 Day Avg. Volume11,361,453
30 Day Avg. Volume11,724,623
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)10.95
Price to Sales (P/S)3.54
P/FCF Ratio26.33
Enterprise Value/Market Cap2.02
Enterprise Value/Revenue6.60
Enterprise Value/Gross Profit8.80
Enterprise Value/Ebitda92.41
Forecast
1Y Price Target
$42.88Price Target Upside26.59% Upside
Rating ConsensusHold
Number of Analyst Covering12
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Acquisition And Product ExpansionAcquisition of an at-home lab testing business and integration of its scientific leadership could enable end-to-end diagnostic capabilities on the platform, supporting differentiated services and higher downstream prescription conversion.
Capital Allocation And Share RepurchaseBoard authorization of a sizable share repurchase program signals management confidence and could support per-share metrics by reducing floating share count.
User Engagement And Traffic RecoveryAccelerating monthly active user metrics and a reversal in website visit declines could strengthen retention and monetization potential across subscription and prescription offerings.
Bears Say
Competition And Pricing Pressure In Weight-loss TherapiesIntensifying competition and branded drug price compression in the weight-loss category may erode demand for compounded offerings and weaken the company’s cost differentiation.
Declining Operational KPIs And Revenue RiskSustained declines in new customer orders, app downloads, and total order volumes point to near-term revenue risk and could raise customer acquisition costs if trends persist.
Margin Pressure From Strategic InvestmentsA major investment phase in talent, technology, and supply chain verticalization is likely to pressure earnings margins and make near-term profitability targets harder to achieve.
Hims & Hers Health News
HIMS FAQ
What was Hims & Hers Health’s price range in the past 12 months?
Hims & Hers Health lowest stock price was $23.97 and its highest was $72.98 in the past 12 months.
What is Hims & Hers Health’s market cap?
Hims & Hers Health’s market cap is $7.21B.
When is Hims & Hers Health’s upcoming earnings report date?
Hims & Hers Health’s upcoming earnings report date is Mar 02, 2026 which is in 48 days.
How were Hims & Hers Health’s earnings last quarter?
Hims & Hers Health released its earnings results on Nov 03, 2025. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.094 by -$0.034.
Is Hims & Hers Health overvalued?
According to Wall Street analysts Hims & Hers Health’s price is currently Undervalued.
Does Hims & Hers Health pay dividends?
Hims & Hers Health does not currently pay dividends.
What is Hims & Hers Health’s EPS estimate?
Hims & Hers Health’s EPS estimate is 0.05.
How many shares outstanding does Hims & Hers Health have?
Hims & Hers Health has 219,270,890 shares outstanding.
What happened to Hims & Hers Health’s price movement after its last earnings report?
Hims & Hers Health reported an EPS of $0.06 in its last earnings report, missing expectations of $0.094. Following the earnings report the stock price went down -3.604%.
Which hedge fund is a major shareholder of Hims & Hers Health?
Currently, no hedge funds are holding shares in HIMS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hims & Hers Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$42.88 (26.59% Upside)
$42.88 (26.59% Upside)
Blogger Sentiment
Bullish
HIMS Sentiment 84%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 2.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $97.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 1.0%
Last 30 Days ▼ 1.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
31.63%
12-Months-Change
Fundamentals
Return on Equity
26.21%
Trailing 12-Months
Asset Growth
270.82%
Trailing 12-Months
Company Description
Hims & Hers Health
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
HIMS Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presents a strong performance with significant revenue growth, strategic partnerships, and international expansion. However, there are challenges in gross margins and increased G&A costs. The company's strategy and future outlook remain optimistic.View all HIMS earnings summariesHIMS Revenue Breakdown
96.60% Online
3.40% Wholesale
HIMS Stock 12 Month Forecast
Average Price Target
$42.88
▲(26.59% Upside)
Technical Analysis
Ownership Overview
5.10% Insiders
25.28% Mutual Funds
0.12% Other Institutional Investors
48.83% Public Companies and Individual Investors